Cargando…
Neoadjuvant chemotherapy for upper tract urothelial carcinoma
Upper tract urothelial carcinoma (UTUC) is a very uncommon disease that occupies for <5% of all urothelial cancers. Radical nephroureterectomy (RNU) remains the standard-of-care for UTUC; however, when patients with locally advanced UTUC are treated with RNU only, the recurrence rate is high. The...
Autores principales: | Kim, Do Kyung, Cho, Kang Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798340/ https://www.ncbi.nlm.nih.gov/pubmed/35117267 http://dx.doi.org/10.21037/tcr.2020.03.08 |
Ejemplares similares
-
Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
por: Ko, Young Hwii
Publicado: (2020) -
Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020) -
The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
por: Kang, Ho Won, et al.
Publicado: (2020) -
The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma
por: Nagata, Yujiro, et al.
Publicado: (2020) -
Current perspectives on novel systemic therapeutic agents beyond immune checkpoint inhibition in metastatic urothelial carcinoma
por: Choi, Hoon, et al.
Publicado: (2020)